Provided by Tiger Trade Technology Pte. Ltd.

LIVZON PHARMA

29.320
+0.4201.45%
Volume:559.40K
Turnover:16.31M
Market Cap:26.04B
PE:13.09
High:29.420
Open:28.900
Low:28.840
Close:28.900
52wk High:41.850
52wk Low:23.940
Shares:888.00M
HK Float Shares:300.00M
Volume Ratio:0.60
T/O Rate:0.19%
Dividend:1.24
Dividend Rate:4.23%
EPS(LYR):2.239
ROE:16.43%
ROA:6.38%
PB:1.65
PE(LYR):13.09
PS:1.95

Loading ...

Livzon Pharmaceutical Group Inc. (1513) Announces 2025 First Extraordinary General Meeting Arrangements

Bulletin Express
·
Nov 10, 2025

LIVZON PHARMACEUTICAL GROUP INC. (Stock Code: 1513) Announces 2025 First EGM Notice

Bulletin Express
·
Nov 10, 2025

Livzon Pharmaceutical (01513) Announces Next Day Disclosure Return and Updated Share Repurchase Details

Bulletin Express
·
Nov 06, 2025

LIVZON PHARMA (01513) Repurchases 163,400 A Shares for RMB5.9971 Million on November 6

Stock News
·
Nov 06, 2025

Livzon Pharmaceutical Group Inc. (01513.HK / 000513.SZ) Releases Next Day Disclosure Return with Unchanged Share Capital and Continued A-Share Buybacks

Bulletin Express
·
Nov 05, 2025

Next Day Disclosure Return

Bulletin Express
·
Nov 04, 2025

Livzon Pharmaceutical Group Inc. (01513) Releases Monthly Return for October 2025

Bulletin Express
·
Nov 04, 2025

LIVZON PHARMA (01513) Repurchased 15.38 Million A Shares by End-October

Stock News
·
Nov 03, 2025

Livzon Pharmaceutical Group Inc. Announces Revised Articles of Association

Bulletin Express
·
Oct 23, 2025

Livzon Pharmaceutical Group Inc. (Livzon) Announces ESG Committee Terms of Reference

Bulletin Express
·
Oct 23, 2025

Livzon Pharmaceutical Group Inc.* Publishes Updated Terms of Reference for the Audit Committee (Adopted 23 October 2025)

Bulletin Express
·
Oct 23, 2025

Livzon Pharmaceutical Group Inc. Updates Nomination Committee Terms of Reference

Bulletin Express
·
Oct 23, 2025

Livzon Pharmaceutical Group Inc. Updates Remuneration and Assessment Committee Terms (23 October 2025)

Bulletin Express
·
Oct 23, 2025

Livzon Pharmaceutical Group Inc. (1513) Releases Third Quarter 2025 Results

Bulletin Express
·
Oct 23, 2025

Livzon Pharmaceutical Group Inc. Announces Cancellation of Supervisory Committee and Amendments to Articles of Association

Bulletin Express
·
Oct 23, 2025

LIVZON PHARMA (01513) Reports Q1-Q3 Results with Net Profit of 1.754 Billion RMB, Up 4.86% Year-on-Year

Stock News
·
Oct 23, 2025

LIVZON PHARMA (01513): Tian Qiusheng and Huang Jinhua Resign as Independent Non-Executive Directors

Stock News
·
Oct 14, 2025

LIVZON PHARMA (01513) Repurchases Total of 15.38 Million A-Shares as of End of September

Stock News
·
Oct 09, 2025

LIVZON PHARMA (01513) Repurchases 129,300 A-Shares for RMB 4.9976 Million on September 25

Stock News
·
Sep 25, 2025

LIVZON PHARMA (01513) Spends RMB 4.9987 Million to Repurchase 127,200 A-Shares on September 19

Stock News
·
Sep 19, 2025